Company intelligence / Profile preview

Pharmalytical Consulting

San Diego, California, USApharmalytical-consulting.com ↗

Ownership: Private
Development stage: Other

Overview

Pharmalytical Consulting specializes in phase-appropriate CMC pharmaceutical development, offering project management and technical expertise across formulation, process development, regulatory strategy, quality control, validation, and technical writing. The founder has led successful programs resulting in commercialized products such as Symlin® (pramlintide acetate injection), Byetta® (exenatide injection), and Targretin® (bexarotene capsules)

Modalities: Small moleculePeptideProteinBiologicParenteralsDrug-device combination products
Industry: Consulting

Beyond the preview

Go deeper on Pharmalytical Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmalytical Consulting.

Explore the full profile